找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Neuroendocrine Neoplasia Management; New Approaches for D Giordano Beretta,Alfredo Berruti,Orlando Goletti Book 2021 Springer Nature Switze

[復(fù)制鏈接]
樓主: Adams
31#
發(fā)表于 2025-3-26 21:22:02 | 只看該作者
Book 2021ostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptortreatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging res
32#
發(fā)表于 2025-3-27 01:18:06 | 只看該作者
33#
發(fā)表于 2025-3-27 08:53:14 | 只看該作者
Epidemiology of Neuroendocrine Neoplasms highest incidence rate whereas the Asian population the lowest. Neuroendocrine neoplasms are typical of adults (65?years or older) and have a slight predominance in males compared to females. Neuroendocrine neoplasms’ most common sites are lung and gastrointestinal pancreatic sites. Neuroendocrine
34#
發(fā)表于 2025-3-27 13:16:28 | 只看該作者
35#
發(fā)表于 2025-3-27 15:01:26 | 只看該作者
Molecular Biology of Neuroendocrine Tumorsnd prognostic stratification of these neoplasms is therefore challenging, and histopathological classifications have been progressively integrated with biomolecular findings to improve patients’ treatment and understanding of the disease..The first hints about the molecular landscape of neuroendocri
36#
發(fā)表于 2025-3-27 20:00:57 | 只看該作者
Circulating Biochemical Markers of Gastro-Entero-Pancreatic (GEP) Neuroendocrine Neoplasms (NENs) have been increasing over the past years partly due to increased awareness and improvements in instrumental diagnostic techniques so that a growing number of clinicians are facing this disease..Management of NEN represents a clinical challenge because of its late presentation, scarcity of standardi
37#
發(fā)表于 2025-3-27 23:47:00 | 只看該作者
Advances in Diagnostic Imagingportance during the last decades, not only to diagnose tumours responsible for particular syndromes but also to select patients for the most appropriate therapies and monitor the diseases during their course..Surgical and medical therapies are guided with imaging in order to give the best chance of
38#
發(fā)表于 2025-3-28 04:27:01 | 只看該作者
39#
發(fā)表于 2025-3-28 06:38:23 | 只看該作者
New Surgical Strategiesinstay for their management as it represents the only possibility of reaching a definitive cure. GEP-NENs are characterized by a high level of heterogeneity, in terms of both clinical presentation and disease aggressiveness. Therefore, their surgical treatment should be tailored taking into account
40#
發(fā)表于 2025-3-28 13:00:48 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 10:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
托克逊县| 常宁市| 独山县| 泌阳县| 五大连池市| 鄂州市| 理塘县| 绩溪县| 凤翔县| 舒城县| 名山县| 陵川县| 铜川市| 连云港市| 怀化市| 临潭县| 甘谷县| 突泉县| 灌南县| 丁青县| 宣武区| 历史| 宁南县| 大足县| 泸州市| 来宾市| 荆州市| 肇源县| 香河县| 洛南县| 旺苍县| 安阳市| 根河市| 荔波县| 郓城县| 海原县| 齐河县| 清水县| 铁岭县| 德昌县| 香港|